InvestorsHub Logo
Followers 2
Posts 352
Boards Moderated 0
Alias Born 04/02/2013

Re: SJSTOCKSHARK post# 566

Wednesday, 03/25/2015 11:28:42 AM

Wednesday, March 25, 2015 11:28:42 AM

Post# of 6405
The genetics and biochemistry are over my head but the implications of that discussion are clear. There are many diseases that could be treated with interfering RNA molecules. One type of leukemia and triple negative breast cancer were mentioned but "drug delivery" was said to be the problem.
We have a significant amount of data showing that Bio-Path's neutral liposomal delivery system has solved that problem. We need that phase II data to prove it to everyone else.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BPTH News